HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz ...

Fintel reports that on December 7, 2023, UBS initiated coverage of Bio-Rad Laboratories Inc. - (NYSE:BIO) with a Buy recommendation. As of November 27, 2023, the average one-year price target for ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12, Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered solid fourth-quarter ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...

Hello, everyone, and welcome to today's Bio-Rad Third Quarter 2024 Results Conference Call and Webcast. At this time to get started, all participants are in a listen-only mode. Later, you will have ...

Bio-Rad Laboratories ( (BIO)) has realeased its Q3 earnings. Here is a breakdown of the information Bio-Rad Laboratories presented to its investors. Bio-Rad Laboratories, Inc., based in Hercules, ...

Thank you for standing by. My name is Prila [ph] and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad Fourth Quarter and Full Year 2024 Results ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform ...

Q4 2025 Net Sales: $693 million, a 3.9% increase from Q4 2024. Q4 2025 Gross Margin: 49.8% GAAP, 52.5% non-GAAP. Q4 2025 Operating Loss: $119 million, including $173 million in impairment charges. Q4 ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International ...